Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GE HealthCare Technologies (GEHC) Exchange Rate Effect (2022 - 2025)

Historic Exchange Rate Effect for GE HealthCare Technologies (GEHC) over the last 4 years, with Q4 2025 value amounting to -$2.0 million.

  • GE HealthCare Technologies' Exchange Rate Effect rose 9733.33% to -$2.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $66.0 million, marking a year-over-year increase of 18571.43%. This contributed to the annual value of $66.0 million for FY2025, which is 18571.43% up from last year.
  • As of Q4 2025, GE HealthCare Technologies' Exchange Rate Effect stood at -$2.0 million, which was up 9733.33% from -$16.0 million recorded in Q3 2025.
  • In the past 5 years, GE HealthCare Technologies' Exchange Rate Effect registered a high of $57.0 million during Q2 2025, and its lowest value of -$75.0 million during Q4 2024.
  • In the last 4 years, GE HealthCare Technologies' Exchange Rate Effect had a median value of -$7.0 million in 2022 and averaged -$1.5 million.
  • As far as peak fluctuations go, GE HealthCare Technologies' Exchange Rate Effect skyrocketed by 36666.67% in 2023, and later crashed by 41250.0% in 2024.
  • Over the past 4 years, GE HealthCare Technologies' Exchange Rate Effect (Quarter) stood at $37.0 million in 2022, then tumbled by 35.14% to $24.0 million in 2023, then crashed by 412.5% to -$75.0 million in 2024, then surged by 97.33% to -$2.0 million in 2025.
  • Its last three reported values are -$2.0 million in Q4 2025, -$16.0 million for Q3 2025, and $57.0 million during Q2 2025.